National Cancer InstituteOvjeren akaunt

@theNCI

Official Twitter account of the National Cancer Institute, the U.S. government’s lead agency for cancer research. Privacy:

Bethesda, MD
Vrijeme pridruživanja: svibanj 2009.

Tweetovi

Blokirali ste korisnika/cu @theNCI

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @theNCI

  1. Prikvačeni tweet

    What is CAR T-cell therapy? It involves changing a patient’s immune cells in the lab so they'll attack cancer cells.

    Poništi
  2. Today is . Worldwide, cancer deaths are projected to rise to 16 million by 2040. Here's some research led by NCI's Center for Global Health:

    Poništi
  3. Today is . By 2040, worldwide cancer cases are projected to rise to 27 million. Here's more from NCI's Center for Global Health:

    Poništi
  4. proslijedio/la je Tweet

    Another successful Town Hall! I say this frequently, but I can’t stress it enough: I feel like I have the best job in the federal government. I’m grateful to lead such a dedicated and talented group.

    Poništi
  5. Poništi
  6. Poništi
  7. A new study may provide insights into why some melanomas are more likely to spread, or metastasize, than others:

    Poništi
  8. is much less common than other types of skin cancer but much more likely to invade nearby tissue and spread to other parts of the body:

    Poništi
  9. How does the immune system work against cancer? Our video shows 3 types of , including drugs known as immune checkpoint inhibitors:

    Poništi
  10. Researchers are exploring ways to expand the types of immune cells that can be used for , as our infographic explains:

    Poništi
  11. proslijedio/la je Tweet

    Humans have billions of . As helpful as these immune cells are, researchers say they might be getting in the way of for . Find out more.

    Poništi
  12. proslijedio/la je Tweet
    31. sij

    367 new lung squamous cell carcinoma histopathology slides have been released and are now available on the Clinical Proteomic Tumor Analysis Consortium Pathology Portal. Browse the slides here:

    Cancer Imaging Archive. See What's New on The Cancer Imaging Archive CPTAC Pathology Portal. 367 New Pathology Slides, 51 New Cases, Lung Squamous Cell Carcinoma.
    Poništi
  13. Poništi
  14. What are BRCA1 and BRCA2? These genes produce proteins that help repair damaged DNA and, therefore, play a role in ensuring the stability of each cell’s genetic material:

    Poništi
  15. . has published two new administrative supplement programs to promote research continuity and retention. Each program targets a career stage or transition where women’s careers are especially vulnerable. To apply, please see and

    Poništi
  16. proslijedio/la je Tweet
    30. sij
    Odgovor korisnicima

    Thank you for highlighting diversity which is an important topic for us. To learn more about our efforts supporting inclusive entrepreneurship please go to .

    Poništi
  17. proslijedio/la je Tweet

    The Applicant Assistance Program offers application coaching to people who have never received SBIR/STTR funding from the , including women-owned small businesses.

    Prikaži ovu nit
    Poništi
  18. Some patients with genitourinary cancers may be eligible to participate in a clinical trial testing a combination of drugs at the NIH Clinical Center:

    Poništi
  19. An investigational drug has extended the survival of some adults with acute myeloid leukemia. The drug, CC-486, is a pill that can be taken at home:

    Poništi
  20. Genomic study reveals differences in lung tumors from patients with African ancestry compared with those of European ancestry:

    Poništi
  21. Investigators in NCI's Center for Cancer Research have tested an approach called T-cell stimulation for targeting cancers with mutations in the TP53 gene:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·